CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's Net Income Growth by Quarter and Year

Mateon Therapeutics Inc's Net Income results by quarter and year




OXGN Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -0.64 -3.88 -3.33
III Quarter September - -0.79 -3.96 -3.97
II Quarter June -1.19 -2.43 -3.10 -3.59
I Quarter March -0.68 -3.54 -3.64 -3.32
FY   -1.87 -7.40 -14.58 -14.21



OXGN Net Income second quarter 2019 Y/Y Growth Comment
Mateon Therapeutics Inc in the second quarter recorded net loss of $ -1.19 millions.

According to the results reported in the second quarter, Mateon Therapeutics Inc achieved the best Net Income growth in Biotechnology & Drugs industry. While Mateon Therapeutics Inc' s Net Income no change of % ranks overall at the positon no. in the second quarter.




OXGN Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's second quarter 2019 Net Income $ -1.19 millions OXGN's Income Statement
Mateon Therapeutics Inc's second quarter 2018 Net Income $ -2.43 millions Quarterly OXGN's Income Statement
New: More OXGN's historic Net Income Growth >>


OXGN Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Mateon Therapeutics Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's II. Quarter Q/Q Net Income Comment
II. Quarter 2019 results of -1.19 millions by Mateon Therapeutics Inc come out even less good compare to the -0.68 millions in the previous quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Net Income growth. While Mateon Therapeutics Inc's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's II. Quarter Q/Q Net Income Comment
Current results of -1.19 millions by Mateon Therapeutics Inc come out even less good compare to the -0.68 millions in the first quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Net Income growth. While Mateon Therapeutics Inc's Net Income growth quarter on quarter, overall rank is .


Mateon Therapeutics Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Net Income 12 Months Ending $ -3.30 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment


Mateon Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Mateon Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
OXGN's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for OXGN's Competitors
Net Income Growth for Mateon Therapeutics Inc's Suppliers
Net Income Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2019
Select Medical Holdings Corp -0.95 %$ -0.946 millions
Prestige Consumer Healthcare Inc. -1.18 %$ -1.175 millions
Abiomed Inc -1.27 %$ -1.269 millions
Zoetis Inc. -2.88 %$ -2.880 millions
Pra Health Sciences, Inc. -2.90 %$ -2.902 millions
Hca Healthcare, Inc. -4.04 %$ -4.037 millions
Amgen Inc. -5.10 %$ -5.096 millions
Molecular Templates, Inc. -5.59 %$ -5.591 millions
Tenax Therapeutics, Inc. -5.87 %$ -5.871 millions
Anika Therapeutics, Inc. -6.51 %$ -6.510 millions
Standard Diversified Inc. -6.74 %$ -6.739 millions
National Research Corporation -6.98 %$ -6.983 millions
Chemed Corporation -7.72 %$ -7.717 millions
Exelixis, Inc. -9.66 %$ -9.660 millions
Zynex Inc -10.59 %$ -10.587 millions
Edwards Lifesciences Corporation -14.29 %$ -14.291 millions
Hologic, Inc -16.83 %$ -16.829 millions
Acadia Healthcare Company, Inc. -18.15 %$ -18.151 millions
Charles River Laboratories International Inc -18.52 %$ -18.518 millions
Laboratory Corp Of America Holdings -18.54 %$ -18.539 millions
Henry Schein, Inc. -19.19 %$ -19.194 millions
Biotelemetry, Inc. -20.53 %$ -20.529 millions
Luna Innovations Inc -21.27 %$ -21.271 millions
Hanger, Inc. -22.38 %$ -22.378 millions
Tivity Health, Inc. -23.10 %$ -23.096 millions
Pacific Health Care Organization Inc -23.51 %$ -23.512 millions
Becton, Dickinson And Company -24.07 %$ -24.074 millions
Meridian Bioscience Inc -25.58 %$ -25.582 millions
Biolife Solutions Inc -26.44 %$ -26.438 millions
Icu Medical Inc -26.47 %$ -26.473 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PSNX's Profile

Stock Price

PSNX's Financials

Business Description

Fundamentals

Charts & Quotes

PSNX's News

Suppliers

PSNX's Competitors

Customers & Markets

Economic Indicators

PSNX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071